Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003.
Schreiber S, Campieri M, Colombel JF, van Deventer SJ, Feagan B, Fedorak R, Forbes A, Gassull M, Gendre JP, van Hogezand RA, Lofberg R, Modigliani R, Pallone F, Petritsch W, Prantera C, Rampton D, Seibold F, Vatn M, Zeitz M, Rutgeerts P; BMBF Competence Network "Inflammatory Bowel disease". Schreiber S, et al. Among authors: colombel jf. Int J Colorectal Dis. 2001 Feb;16(1):1-11; discussion 12-3. doi: 10.1007/s003840100285. Int J Colorectal Dis. 2001. PMID: 11317691
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soulé JC, Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. Gendre JP, et al. Among authors: colombel jf. Ann Gastroenterol Hepatol (Paris). 1993 Oct;29(5):251-6. Ann Gastroenterol Hepatol (Paris). 1993. PMID: 8250520 Clinical Trial. French.
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soulé JC, Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. Gendre JP, et al. Among authors: colombel jf. Gastroenterology. 1993 Feb;104(2):435-9. doi: 10.1016/0016-5085(93)90411-5. Gastroenterology. 1993. PMID: 8425685 Clinical Trial.
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, Duclos B, Soulé JC, Gendre JP, Galmiche JP, Danne O, Cadiot G, Lamouliatte H, Belaïche J, Mary JY. Modigliani R, et al. Among authors: colombel jf. Gastroenterology. 1996 Mar;110(3):688-93. doi: 10.1053/gast.1996.v110.pm8608877. Gastroenterology. 1996. PMID: 8608877 Clinical Trial.
Clinical characteristics of Crohn's disease in 72 families.
Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Bélaïche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A. Colombel JF, et al. Gastroenterology. 1996 Sep;111(3):604-7. doi: 10.1053/gast.1996.v111.pm8780563. Gastroenterology. 1996. PMID: 8780563
Methotrexate for the treatment of refractory Crohn's disease.
Lémann M, Chamiot-Prieur C, Mesnard B, Halphen M, Messing B, Rambaud JC, Gendre JP, Colombel JF, Modigliani R. Lémann M, et al. Among authors: colombel jf. Aliment Pharmacol Ther. 1996 Jun;10(3):309-14. doi: 10.1111/j.0953-0673.1996.00309.x. Aliment Pharmacol Ther. 1996. PMID: 8791956 Clinical Trial.
Treatment of severe Crohn's disease with anti-CD4 monoclonal antibody.
Canva-Delcambre V, Jacquot S, Robinet E, Lémann M, Drouet C, Labalette M, Dessaint JP, Bengoufa D, Rabian C, Modigliani R, Wijdenes J, Revillard JP, Colombel JF. Canva-Delcambre V, et al. Among authors: colombel jf. Aliment Pharmacol Ther. 1996 Oct;10(5):721-7. doi: 10.1046/j.1365-2036.1996.59201000.x. Aliment Pharmacol Ther. 1996. PMID: 8899079 Clinical Trial.
1,170 results